Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)

Detalhes bibliográficos
Autor(a) principal: Monteiro , Alice
Data de Publicação: 2018
Outros Autores: Góis , Carlos, Lacerda, Cristina, Valério, Elisabete, Xavier , Helena, Dias , Ortélia, Ponte, Sandra, Torcato Parreira, Sara
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://onco.news/index.php/journal/article/view/73
Resumo: The subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments.
id RCAP_7ddee8c7bd83aad4b225c2b12602cc8b
oai_identifier_str oai:oai.onco.news:article/73
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)RituximabTrastuzumabSubcutâneoIntervenções de enfermagemBoas práticasEnfermagem oncológicaRituximabTrastuzumabSubcutaneousNursing interventionsGood practicesCancer nursingThe subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments.As formulações subcutâneas de Trastuzumab (Herceptin®) e Rituximab (MabThera®) têm a vantagem de permitir uma maior comodidade para a pessoa com doença oncológica e maior facilidade na prescrição, preparação e administração. A introdução deste tipo de formulações nos modos de administração de terapêutica antineoplásica exige, por parte dos enfermeiros, uma atualização de conhecimentos, que permita assegurar boas práticas na prestação de cuidados. Com o objetivo de suportar este processo, a Associação de Enfermagem Oncológica Portuguesa desenvolveu dois documentos (“Linhas de Consenso”), com recomendações para os enfermeiros que administram as terapêuticas antineoplásicas Rituximab e Trastuzumab, nas formulações subcutâneas. Um grupo de enfermeiros peritos avaliou a aplicabilidade destes documentos e concluiu que a utilização das “Linhas de Consenso” permite uniformizar procedimentos e orientar as intervenções de enfermagem, o que pode facilitar uma melhoria na educação e acompanhamento da pessoa com doença oncológica.AEOP – Associação de Enfermagem Oncológica Portuguesa2018-06-20info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/73Onco.news; No. 36 (2018): Onco.News Journal (january-june); 20-25Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 20-252183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/73https://onco.news/index.php/journal/article/view/73/90Direitos de Autor (c) 2018 Alice Monteiro , Carlos Góis , Cristina Lacerda, Elisabete Valério, Helena Xavier , Ortélia Dias , Sandra Ponte, Sara Torcato Parreirainfo:eu-repo/semantics/openAccessMonteiro , AliceGóis , CarlosLacerda, CristinaValério, ElisabeteXavier , HelenaDias , OrtéliaPonte, SandraTorcato Parreira, Sara2024-03-16T07:55:16Zoai:oai.onco.news:article/73Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:20.902135Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
Prática de clínica dos enfermeiros portugueses: administração subcutânea de trastuzumab (herceptin®) e rituximab (mabthera®)
title Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
spellingShingle Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
Monteiro , Alice
Rituximab
Trastuzumab
Subcutâneo
Intervenções de enfermagem
Boas práticas
Enfermagem oncológica
Rituximab
Trastuzumab
Subcutaneous
Nursing interventions
Good practices
Cancer nursing
title_short Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
title_full Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
title_fullStr Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
title_full_unstemmed Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
title_sort Nurses' clinical practice Portuguese: subcutaneous administration of trastuzumab (herceptin®) and rituximab (mabthera®)
author Monteiro , Alice
author_facet Monteiro , Alice
Góis , Carlos
Lacerda, Cristina
Valério, Elisabete
Xavier , Helena
Dias , Ortélia
Ponte, Sandra
Torcato Parreira, Sara
author_role author
author2 Góis , Carlos
Lacerda, Cristina
Valério, Elisabete
Xavier , Helena
Dias , Ortélia
Ponte, Sandra
Torcato Parreira, Sara
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Monteiro , Alice
Góis , Carlos
Lacerda, Cristina
Valério, Elisabete
Xavier , Helena
Dias , Ortélia
Ponte, Sandra
Torcato Parreira, Sara
dc.subject.por.fl_str_mv Rituximab
Trastuzumab
Subcutâneo
Intervenções de enfermagem
Boas práticas
Enfermagem oncológica
Rituximab
Trastuzumab
Subcutaneous
Nursing interventions
Good practices
Cancer nursing
topic Rituximab
Trastuzumab
Subcutâneo
Intervenções de enfermagem
Boas práticas
Enfermagem oncológica
Rituximab
Trastuzumab
Subcutaneous
Nursing interventions
Good practices
Cancer nursing
description The subcutaneous formulations of Trastuzumab (Herceptin®) and Rituximab (MabThera®) are more comfortable for the people affected by cancer who need this type of treatment and are also easier to prescribe, prepare and administer. This type of formulations demands nurses to update their knowledge, so that good practices are assured in the health care setting. With the purpose to support nurses in this matter, the Portuguese Oncology Nursing Association developed two documents with recommendations for administration of subcutaneous Rituximab and Trastuzumab. A group of expert cancer nurses evaluated the applicability of those documents and concluded that they facilitate to standardize procedures and to guide nursing interventions, which might help in the education and follow-up of the people affected by cancer who are under this type of anti-cancer treatments.
publishDate 2018
dc.date.none.fl_str_mv 2018-06-20
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://onco.news/index.php/journal/article/view/73
url https://onco.news/index.php/journal/article/view/73
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://onco.news/index.php/journal/article/view/73
https://onco.news/index.php/journal/article/view/73/90
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
publisher.none.fl_str_mv AEOP – Associação de Enfermagem Oncológica Portuguesa
dc.source.none.fl_str_mv Onco.news; No. 36 (2018): Onco.News Journal (january-june); 20-25
Onco.News; N.º 36 (2018): Revista Onco.News (janeiro-junho); 20-25
2183-6914
1646-7868
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138187218518016